Last update :
18/04/2024
References   References 3981  
Type : Journal
Web link : http://dx.doi.org/10.1136/ejhpharm-2016-000980

Research teams : Wuhan - Wuhan University, College of Pharmacy
Authors : He G, Zeng F, Lei K, Xia S, Deng L, Zhang C, Liu D.
Title : Compatibility of dexamethasone sodium phosphate with 5-HT3 receptor antagonists in infusion solutions: a comprehensive study
Reference : EJHP ;24:162?166 2017

Level of Evidence : 
Level of evidence A+
Physical stability : 
Visual examination Particle counting 
Chemical stability : 
High Performance Liquid Chromatography - ultraviolet detector (HPLC-UV)
Stability defined as 95% of the initial concentration
Other methods : 
Comments : 
Degradation products not observed in real conditions

List of drugs
InjectionAzasetron Antiemetic
Compatible 0.2 mg/ml + InjectionDexamethasone sodium phosphate 0.1 & 0.2 mg/ml + Sodium chloride 0,9%
InjectionDexamethasone sodium phosphate Anti-inflammatory
Compatible 0.1 & 0.2 mg/ml + InjectionAzasetron 0.2 mg/ml + Sodium chloride 0,9%
Compatible 0.1 & 0.2 mg/ml + InjectionDolasetron mesylate 0.05 mg/ml + Sodium chloride 0,9%
Compatible 0.1 & 0.2 mg/ml + InjectionDolasetron mesylate 1 mg/ml + Glucose 5%
Compatible 0.1 & 0.2 mg/ml + InjectionOndansetron hydrochloride 0.08 mg/ml + NaCl 0,9% or Glucose 5%
Compatible 0.1 & 0.2 mg/ml + InjectionPalonosetron hydrochloride 2.5 µg/ml + NaCl 0,9% or Glucose 5%
Compatible 0.1 & 0.2 mg/ml + InjectionRamosetron 3 µg/ml + NaCl 0,9% or Glucose 5%
InjectionDolasetron mesylate Antiemetic
Compatible 0.05 mg/ml + InjectionDexamethasone sodium phosphate 0.1 & 0.2 mg/ml + Sodium chloride 0,9%
Compatible 1 mg/ml + InjectionDexamethasone sodium phosphate 0.1 & 0.2 mg/ml + Glucose 5%
InjectionOndansetron hydrochloride Antiemetic
Compatible 0.08 mg/ml + InjectionDexamethasone sodium phosphate 0.1 & 0.2 mg/ml + NaCl 0,9% or Glucose 5%
InjectionPalonosetron hydrochloride Antiemetic
Compatible 2.5 µg/ml + InjectionDexamethasone sodium phosphate 0.1 & 0.2 mg/ml + NaCl 0,9% or Glucose 5%
InjectionRamosetron Antiemetic
Compatible 3 µg/ml + InjectionDexamethasone sodium phosphate 0.1 & 0.2 mg/ml + NaCl 0,9% or Glucose 5%
InjectionTropisetron hydrochloride Antiemetic
Stability of mixtures
Polyolefine NaCl 0,9% or Glucose 5% 23-27°C Light
Injection Dexamethasone sodium phosphate 0,1 mg/ml
Injection Ondansetron hydrochloride 0,08 mg/ml
48 Hour
Polyolefine NaCl 0,9% or Glucose 5% 23-27°C Light
Injection Dexamethasone sodium phosphate 0,2 mg/ml
Injection Ondansetron hydrochloride 0,08 mg/ml
48 Hour
Polyolefine NaCl 0,9% or Glucose 5% 23-27°C Light
Injection Dexamethasone sodium phosphate 0,2 mg/ml
Injection Palonosetron hydrochloride 2.5 µg/ml
48 Hour
Polyolefine NaCl 0,9% or Glucose 5% 23-27°C Light
Injection Dexamethasone sodium phosphate 0,1 mg/ml
Injection Palonosetron hydrochloride 2.5 µg/ml
48 Hour
Polyolefine NaCl 0,9% or Glucose 5% 23-27°C Light
Injection Ramosetron 3 µg/ml
Injection Dexamethasone sodium phosphate 0,1 mg/ml
48 Hour
Polyolefine NaCl 0,9% or Glucose 5% 23-27°C Light
Injection Dexamethasone sodium phosphate 0.2 mg/ml
Injection Ramosetron 3 µg/ml
48 Hour
Polyolefine Sodium chloride 0,9% 23-27°C Light
Injection Dexamethasone sodium phosphate 0,2 mg/ml
Injection Tropisetron hydrochloride 0,05 mg/ml
48 Hour
Polyolefine Sodium chloride 0,9% 23-27°C Light
Injection Tropisetron hydrochloride 0,05 mg/ml
Injection Dexamethasone sodium phosphate 0,1 mg/ml
48 Hour
Polyolefine Sodium chloride 0,9% 23-27°C Light
Injection Dexamethasone sodium phosphate 0,1 mg/ml
Injection Dolasetron mesylate 1 mg/ml
48 Hour
Polyolefine Sodium chloride 0,9% 23-27°C Light
Injection Dexamethasone sodium phosphate 0,2 mg/ml
Injection Dolasetron mesylate 1 mg/ml
48 Hour
Polyolefine Sodium chloride 0,9% 23-27°C Light
Injection Azasetron 0,2 mg/ml
Injection Dexamethasone sodium phosphate 0,1 mg/ml
48 Hour
Polyolefine Sodium chloride 0,9% 23-27°C Light
Injection Dexamethasone sodium phosphate 0,2 mg/ml
Injection Azasetron 0,2 mg/ml
48 Hour

  Mentions Légales